044960 — Eagle Veterinary Technology Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapContrarian

Market Cap
KR₩53bn
Enterprise Value
KR₩51bn
Revenue
KR₩42bn

Annual income statement for Eagle Veterinary Technology Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	—	—	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	40,357	40,437	43,540	42,794	41,717
Cost of Revenue
Gross Profit	12,182	14,334	14,818	14,545	14,033
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	37,046	36,373	40,111	39,594	38,250
Operating Profit	3,311	4,064	3,428	3,199	3,467
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	2,929	3,875	3,429	3,520	4,413
Provision for Income Taxes
Net Income After Taxes	2,459	3,638	2,643	2,976	3,705
Net Income Before Extraordinary Items
Net Income	2,459	3,638	2,643	2,976	3,705
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	2,459	3,638	2,643	2,976	3,705
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	199	296	214	243	301
Dividends per Share